CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
2.665
+0.015 (0.57%)
At close: Apr 16, 2024, 4:00 PM
2.630
-0.035 (-1.31%)
Pre-market: Apr 17, 2024, 4:02 AM EDT

CureVac Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 20222021202020192018
Revenue
67.42102.9948.8717.4212.87
Revenue Growth (YoY)
-34.54%110.74%180.61%35.31%-
Cost of Revenue
183.99238.214.1727.9817.74
Gross Profit
-116.57-135.2134.7-10.57-4.87
Selling, General & Admin
107102.1554.2950.7226.37
Research & Development
62.55815.91113.8143.2441.72
Other Operating Expenses
-36.66-640.99-23.58-5.04-0.15
Operating Expenses
132.88277.06144.5188.9367.95
Operating Income
-249.46-412.26-109.82-99.5-72.82
Interest Expense / Income
3.7110.3422.11.460.28
Other Expense / Income
-4.01-10.1-2.07-0.83-1.97
Pretax Income
-249.16-412.5-129.85-100.13-71.13
Income Tax
-0.13-0.78-0.73-0.250.11
Net Income
-249.03-411.72-129.12-99.87-71.24
Shares Outstanding (Basic)
190187176176-
Shares Change
1.73%6.00%---
EPS (Basic)
-1.32-2.21-0.98-1.03-0.74
EPS (Diluted)
-1.32-2.21-0.98-1.03-0.74
Free Cash Flow
-374.2-857.35486.07-98.14-83.52
Free Cash Flow Per Share
-1.97-4.582.75-0.56-
Gross Margin
-172.91%-131.28%71.00%-60.67%-37.86%
Operating Margin
-370.00%-400.29%-224.70%-571.30%-565.80%
Profit Margin
-369.37%-399.76%-264.21%-573.46%-553.50%
Free Cash Flow Margin
-555.03%-832.46%994.61%-563.48%-648.87%
EBITDA
-221.71-386.49-97.07-91.5-67.08
EBITDA Margin
-328.84%-375.27%-198.63%-525.38%-521.13%
Depreciation & Amortization
23.7415.6710.677.163.78
EBIT
-245.45-402.16-107.75-98.67-70.86
EBIT Margin
-364.06%-390.48%-220.47%-566.52%-550.51%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).